Recombinant Influenza B (B/Florida/4/2006) Nucleoprotein/NP Protein (His Tag) | PKSQ050003

Recombinant Influenza B (B/Florida/4/2006) Nucleoprotein/NP Protein (His Tag) | PKSQ050003 | Gentaur US, UK & Europe Disrtribition

Synonyms: NP Protein, Influenza B;Nucleoprotein Protein, Influenza B

Active Protein: N/A

Activity: A DNA sequence encoding the Influenza B (B/Florida/4/2006) nucleoprotein (ACF54251.1) (Met1-Tyr560) was expressed with a polyhistidine tag at the C-terminus.

Protein Construction: A DNA sequence encoding the Influenza B (B/Florida/4/2006) nucleoprotein (ACF54251.1) (Met1-Tyr560) was expressed with a polyhistidine tag at the C-terminus.

Fusion Tag: C-His

Species: Influenza B

Expressed Host: Baculovirus-Insect Cells

Shipping: This product is provided as lyophilized powder which is shipped with ice packs.

Purity: > 90 % as determined by reducing SDS-PAGE.

Endotoxin: < 1.0 EU per µg of the protein as determined by the LAL method.

Stability and Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Molecular Mass: 63.1 kDa

Formulation: Lyophilized from sterile 20 mM PB, 500 mM NaCl, pH 7.0, 10 % glycerol, 15% trehalose.

Reconstitution: Please refer to the printed manual for detailed information.

Background: CD81, also known as TAPA-1, belongs to the transmembrane 4 superfamily, also known as the tetraspanin family. Members of this family mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility.CD81 is a widely expressed cell-surface protein involved in an astonishing variety of biologic responses. It is related to adhesion, morphology, activation, proliferation, and differentiation of B, T, and other cells. On B cells CD81 is part of a complex with CD21, CD19, and Leu13. This complex reduces the threshold for B cell activation via the B cell receptor by bridging Ag specific recognition and CD21-mediated complement recognition.

Research Area: N/A